Publication
Revies Articles
- 「δ Opioid Receptor Inverse Agonists and their In Vivo Pharmacological Effects」
Hirayama, S.; Fujii, H.
Curr. Top. Med. Chem. Ed. By Fujii, H., Bentham Science, 20, 31, pp.2889–2902, 2020.
- 「Exploring μ-Opioid Receptor Splice Variants as a Specific Molecular Target for New Analgesics」
Mizoguchi, H.; Fujii, H.
Curr. Top. Med. Chem. Ed. By Fujii, H., Bentham Science, 20, 31, pp.2866–2877, 2020.
- Dibenzofuran-4,6-bis(oxazoline) (DBFOX). A novel trans-chelating bis(oxazoline) ligand for asymmetric reactions.
Itoh, K.;, Sibi, M. P.
Org. Biomol. Chem., Vol.16, pp.5551-5565, 2018.
- オピオイド受容体スプライスバリアント
藤井秀明, 平山重人
ペインクリニック, Vol.38, pp.S196-S202, 2017.
- Essential Structure of the κ Opioid Receptor Agonist Nalfurafine for Binding to the κ Receptor.
Nagase,H.; Fujii, H.
Curr. Pharm. Des., Vol.20, pp.7400-7414, 2014.
- Non-peptidic δ Opioid Receptor Agonists and Antagonists (2000-2012)
Fujii, H.; Takahashi, T.; Nagase, H.
Exp. Opin. Ther. Patents, Vol.23, No.9, pp.1181-1208, 2013.
- Design and Synthesis of Novel Opioid Ligands and Their Pharmacologies.
Nagase, H.; Fujii, H.
Heterocycles, Vol.85, No.8, pp.1821-1867, 2012.
- 受容体オリゴマーの新展開 -新たな創薬標的としての可能性-
藤井秀明, 平山重人, 長瀬 博
化学, Vol.66, No.9, pp.70-71, 2011.
- Rational Drug Design of Selective εOpioid Receptor Agonist TAN-821 and Antagonist TAN-1014.
Fujii, H.; Nagase, H.
Curr. Med. Chem., 13, pp.1109-1118, 2006.
Copyright (C) 2008 Laboratory of Medicinal Chemistry. All rights reserved.